Spain's LETI Laboratories Launches Leading Atopic Skincare Line to U.S. Market

June 17, 2014

DermWORX Professional Skincare and LETI Laboratories, headquartered in Barcelona, Spain, will launch a series of top European dermatological products in the United States.

The series includes: LETI's leading dermatology line for atopic skin, AT4, which DermWORX will market to U.S. healthcare professionals and their patients beginning in Q3, 2014. In addition to the introduction of LETI atopic line, future plans are to introduce additional LETI lines in the U.S. and potentially expand DermWORX products internationally.

Jaime Grego, President of LETI said, “For nearly 100 years, LETI has earned the loyalty of physicians and their patients with safe and effective solutions like AT4. We are thrilled to make these products available in the United States through our partnership with DermWORX.”

“DermWORX is fortunate to have LETI as a strategic partner, as it provides us the opportunity to introduce proven, effective and successful products into the U.S. market for patients who very much need them. Atopic skin is different from normal skin and requires specialized care - from cleansers to moisturizers. AT4 fills this need in a meaningful way," said Tom Ford, Chief Executive Officer of DermWORX.

Visit www.DermWORX.com or www.leti.com/en for more information.

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free